Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 2 | $2,199,167 |
| Sells | 8 | $12,855 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 03 Jan 2025 16:15 | XLO | Xilio Therapeutics Inc | FRANKENFIELD CHRISTOPHER JAMES | Chief Financial Officer | 02 Jan 2025 | Sale | 6,954 | 0.9837 | 6,841 | D |
| 03 Jan 2025 16:15 | XLO | Xilio Therapeutics Inc | BRENNAN KEVIN M. | SVP, FINANCE AND ACCOUNTING | 02 Jan 2025 | Sale | 1,803 | 0.9837 | 1,774 | D |
| 19 Dec 2024 16:19 | XLO | Xilio Therapeutics Inc | GILEAD SCIENCES, INC. | 10% | 18 Dec 2024 | Purchase | 1,759,978 | 1.04 | 1,830,377 | D |
| 03 Apr 2024 18:50 | XLO | Xilio Therapeutics Inc | GILEAD SCIENCES, INC. | 10% | 02 Apr 2024 | Purchase | 485,250 | 0.76 | 368,790 | D |
| 09 Feb 2024 16:33 | XLO | Xilio Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 08 Feb 2024 | Sale | 267 | 0.64 | 171 | I |
| 09 Feb 2024 16:33 | XLO | Xilio Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 08 Feb 2024 | Sale | 733 | 0.64 | 469 | D |
| 16 Jan 2024 18:16 | XLO | Xilio Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 12 Jan 2024 | Sale | 560 | 0.83 | 465 | I |
| 16 Jan 2024 18:16 | XLO | Xilio Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 11 Jan 2024 | Sale | 569 | 0.87 | 495 | I |
| 16 Jan 2024 18:16 | XLO | Xilio Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 12 Jan 2024 | Sale | 1,540 | 0.83 | 1,278 | D |
| 16 Jan 2024 18:16 | XLO | Xilio Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 11 Jan 2024 | Sale | 1,566 | 0.87 | 1,362 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)